Tanya Laidlaw is a Rheumatology/Immunology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 292 publications with 12,961 citations (h-index 47); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156110
Telephone
617-732-5500Registry record last updated 7 Aug 2012.
Clinical trials
- Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
Sponsor: Brigham and Women's Hospital
- Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20253 payments
- GENZYME CORPORATIONProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- Patient Phenotyping, Sampling, and Biorepository
Brigham and Women'S Hospital
FY2026$245,815U19AI095219 - Patient-Oriented Research Mentorship and Training in Upper Airway Allergic and Inflammatory Diseases
Brigham and Women'S Hospital
FY2026$174,031K24AI180296 - Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
Brigham and Women'S Hospital
FY2025$414,631U19AI095219
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Journal of Asthma and Allergy
2023 - Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease
Journal of Allergy and Clinical Immunology
2022 - Updates on immune mechanisms in aspirin-exacerbated respiratory disease
Journal of Allergy and Clinical Immunology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”